Renergen develops pioneering Covid-19 vaccine transport vessel
SA company says its solution to sub-zero transportation of vaccines simplifies logistics
Renergen, an emerging domestic natural gas and helium producer, has developed a ground-breaking device that keeps Covid-19 vaccines ultra-cold during transportation for up to 30 days, allowing for the vaccines to travel for longer and reach remote areas.
The Renergen Cryo-Vacc will simplify the logistics of moving vaccines at extremely cold temperatures of between -70°C and -150°C for more than four weeks and without the need for any power supply...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.